Aleve (naproxen sodium) is not particularly effective for nerve pain. It was designed to reduce inflammation, and while nerve injuries do involve some inflammation, the primary drivers of neuropathic pain are misfiring nerve signals that naproxen doesn’t meaningfully address. Nerve pain is not an FDA-approved indication for Aleve, and the clinical evidence for using any over-the-counter NSAID for this purpose is weak.
That said, the picture isn’t completely black and white. The type of nerve pain you’re dealing with matters. Aleve may offer modest relief when a nerve is being physically compressed, like in sciatica, but it performs poorly for conditions where the nerve itself is damaged, like diabetic neuropathy or shingles-related pain.
Why Aleve Falls Short for Nerve Pain
Aleve works by blocking the production of prostaglandins, chemicals your body makes during inflammation. This makes it effective for swollen joints, muscle strains, and other inflammatory conditions. Nerve injuries do trigger some prostaglandin production, which increases electrical activity in pain-sensing neurons. So in theory, blocking prostaglandins could help.
In practice, it doesn’t seem to matter much. A Cochrane review, the gold standard for evaluating medical evidence, looked at oral NSAIDs for neuropathic pain and found no good evidence that they help. The available studies included only 251 participants total, most of whom were testing an experimental drug never used in clinical practice. Among the handful of patients actually taking a standard NSAID for confirmed nerve pain, there was no indication of significant pain reduction. The review’s conclusion was blunt: there is no evidence to support or refute the use of oral NSAIDs for neuropathic pain conditions.
The core problem is that neuropathic pain isn’t primarily an inflammation problem. It’s a signaling problem. Damaged nerves fire spontaneously, amplify normal sensations into painful ones, and create feedback loops in the spinal cord and brain. Prostaglandin blockers simply don’t reach these mechanisms in a meaningful way.
Aleve for Sciatica: Modest at Best
Sciatica is one nerve pain condition where Aleve gets tested most often, because a herniated disc pressing on a nerve root creates genuine inflammation. A Norwegian randomized controlled trial gave 123 patients with moderate to severe sciatica either naproxen 500 mg or a placebo twice daily for 10 days. Naproxen did reduce leg pain more than the placebo, but the difference was small: about half a point on a 0-to-10 pain scale on average, reaching roughly one full point by day 10.
To put that in practical terms, about 10 patients would need to take naproxen for one of them to achieve even a 30% reduction in leg pain. For a 50% reduction, the number jumps to roughly 21 patients treated per one success. The two groups didn’t differ in how bothersome the sciatica felt overall or in their use of stronger pain medications. Researchers characterized the benefit as “small” and “likely clinically unimportant” for moderate to severe cases. If your sciatica is mild, Aleve may take enough of the edge off to be worth trying. For more severe nerve compression, you’ll likely need something else.
What Actually Works for Nerve Pain
The medications with the strongest evidence for neuropathic pain work on nerve signaling directly rather than on inflammation. These fall into a few categories.
- Nerve-stabilizing medications like gabapentin and pregabalin calm overactive nerve signals. They’re among the most commonly prescribed options for conditions like diabetic neuropathy and post-shingles pain, though they can cause drowsiness, dizziness, and cognitive fog. In one trial focused on cervical radiculopathy (a pinched nerve in the neck), 45% of patients on gabapentin experienced side effects.
- Certain antidepressants that affect both serotonin and norepinephrine can dampen pain signals traveling through the spinal cord. These are often used as first-line treatments for diabetic nerve pain and fibromyalgia-related nerve symptoms.
- Topical treatments applied directly to the painful area can help with localized nerve pain. Three FDA-approved topical options exist for neuropathic pain: two lidocaine-based patches (approved for post-shingles pain) and a high-concentration capsaicin patch (approved for both post-shingles pain and diabetic nerve pain). These have strong clinical evidence behind them and avoid the systemic side effects of oral medications.
Interestingly, for one specific type of nerve pain, cervical radiculopathy, a large retrospective study found that patients prescribed gabapentin actually had worse outcomes than those given NSAIDs. The gabapentin group had higher rates of opioid prescriptions, more adverse events, and more follow-up procedures. No outcome favored gabapentin over NSAIDs for that condition. This highlights that “nerve pain” isn’t one thing, and the best treatment depends heavily on the specific cause.
Can You Combine Aleve With Nerve Pain Medications?
There are no known drug interactions between naproxen and gabapentin, so taking both simultaneously is generally considered safe from a pharmacological standpoint. Some people find that a combination approach helps, using Aleve to manage any inflammatory component while a nerve-specific medication handles the signaling issues. This can be especially relevant for conditions like radiculopathy, where a compressed nerve root is both inflamed and misfiring.
The limitation is that adding Aleve on top of a nerve medication hasn’t been shown to produce reliably better results in studies. If you’re already on a dedicated nerve pain treatment and wondering whether adding Aleve would help, the benefit is likely to be marginal for most neuropathic conditions.
Safety Considerations for Long-Term Use
Nerve pain is typically chronic, and this creates a mismatch with how Aleve should be used. All NSAIDs carry risks for gastrointestinal bleeding and cardiovascular events when taken regularly. These risks can appear within weeks of consistent use, and they increase at higher doses.
Naproxen does have a slightly more favorable cardiovascular profile compared to other NSAIDs. The International Association for the Study of Pain notes that naproxen and low-dose ibuprofen appear to carry lower cardiovascular risk than other options in this drug class. But “lower risk” is not “no risk,” and the general recommendation for any NSAID is the lowest effective dose for the shortest possible time. That guidance runs directly against the reality of nerve pain, which can persist for months or years. If Aleve isn’t producing clear, noticeable relief for your nerve pain within a week or two, continuing to take it exposes you to accumulating risks without a meaningful payoff.